Hatabah D, Gupta S, Mantus G, Sullivan P, Heilman S, Camacho-Gonzalez A
Vaccines (Basel). 2025; 13(2).
PMID: 40006710
PMC: 11861628.
DOI: 10.3390/vaccines13020163.
Salamony A, Abdelsalam M, Elguindy N, Roshdy W, Youssef A, Shamikh Y
Curr Microbiol. 2025; 82(3):122.
PMID: 39918738
DOI: 10.1007/s00284-025-04095-3.
Castro-Robles B, Cimas F, Arias-Salazar L, Ontanon J, Lozano J, Lopez-Lopez S
Front Immunol. 2025; 15():1471401.
PMID: 39835131
PMC: 11743620.
DOI: 10.3389/fimmu.2024.1471401.
Holder K, Ings D, Fifield K, Barnes D, Barnable K, Harnum D
J Immunol. 2024; 213(8):1105-1114.
PMID: 39248629
PMC: 11457723.
DOI: 10.4049/jimmunol.2400250.
Ciccimarra F, Luxi N, Bellitto C, LAbbate L, Raethke M, van Hunsel F
Vaccines (Basel). 2024; 12(3).
PMID: 38543875
PMC: 10974422.
DOI: 10.3390/vaccines12030241.
Self-reported side effects of COVID-19 vaccines among the public.
Karuppannan M, Ming L, Abdul Wahab M, Mohd Noordin Z, Yee S, Hermansyah A
J Pharm Policy Pract. 2024; 17(1):2308617.
PMID: 38420042
PMC: 10901186.
DOI: 10.1080/20523211.2024.2308617.
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology.
Phan H, Tsitsiklis A, Maguire C, Haddad E, Becker P, Kim-Schulze S
medRxiv. 2024; .
PMID: 38405760
PMC: 10888993.
DOI: 10.1101/2024.02.11.24301704.
Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection.
Suntronwong N, Kanokudom S, Auphimai C, Thongmee T, Assawakosri S, Vichaiwattana P
Vaccines (Basel). 2024; 12(2).
PMID: 38400163
PMC: 10891631.
DOI: 10.3390/vaccines12020180.
Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response.
Zhang Y, Kumanovics A, Wiencek J, Melanson S, Love T, Wu A
Viruses. 2024; 16(2.
PMID: 38400067
PMC: 10891747.
DOI: 10.3390/v16020292.
Safety and efficiency of COVID-19 vaccine in North Africa.
Chelly S, Jaziri S, Ammar A, Ezzi O, Douss N, Saffar S
Hum Vaccin Immunother. 2024; 20(1):2306703.
PMID: 38304972
PMC: 10841012.
DOI: 10.1080/21645515.2024.2306703.
Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel.
Ciccone E, Zhu D, Gunderson A, Hawke S, Ajeen R, Lodge E
Open Forum Infect Dis. 2024; 11(1):ofae009.
PMID: 38293246
PMC: 10826795.
DOI: 10.1093/ofid/ofae009.
What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?.
Ravlic S, Kurtovic T, Cvetko Krajinovic L, Hecimovic A, Milos M, Mateljak Lukacevic S
Hum Vaccin Immunother. 2023; 19(3):2270310.
PMID: 37905722
PMC: 10760325.
DOI: 10.1080/21645515.2023.2270310.
Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity.
Bansal S, Fleming T, Canez J, Maine G, Bharat A, Walia R
Transpl Immunol. 2023; 81:101940.
PMID: 37866672
PMC: 11019873.
DOI: 10.1016/j.trim.2023.101940.
Cancerous Patient, COVID-19 Vaccination, Blood Viscosity and Stroke-Like Complication.
Joob B, Wiwanitkit V
Int J Prev Med. 2023; 14:87.
PMID: 37854991
PMC: 10580184.
DOI: 10.4103/ijpvm.ijpvm_217_21.
Comparison of Antibody Responses After CoronaVac and BNT162b2 Vaccines in Healthcare Workers.
Oktay Gultekin E, Gultekin O
Indian J Microbiol. 2023; 63(3):361-368.
PMID: 37781011
PMC: 10533450.
DOI: 10.1007/s12088-023-01098-1.
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review.
Roslan M, Mohd Nisfu F, Arzmi M, Abdul Wahab R, Zainuddin N
Malays J Med Sci. 2023; 30(4):8-24.
PMID: 37655145
PMC: 10467589.
DOI: 10.21315/mjms2023.30.4.2.
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
Krause R, Moyo-Gwete T, Richardson S, Makhado Z, Manamela N, Hermanus T
NPJ Vaccines. 2023; 8(1):119.
PMID: 37573434
PMC: 10423246.
DOI: 10.1038/s41541-023-00724-9.
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.
Nowill A, Caruso M, de Campos-Lima P
Front Immunol. 2023; 14:1133225.
PMID: 37388738
PMC: 10303130.
DOI: 10.3389/fimmu.2023.1133225.
Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects.
Dulipsingh L, Schaefer E, Wakefield D, Williams K, Halilovic A, Crowell R
Heliyon. 2023; 9(6):e17410.
PMID: 37366522
PMC: 10276490.
DOI: 10.1016/j.heliyon.2023.e17410.
The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence.
Calabro G, Pappalardo C, DAmbrosio F, Vece M, Lupi C, Lontano A
Vaccines (Basel). 2023; 11(5).
PMID: 37243115
PMC: 10222140.
DOI: 10.3390/vaccines11051011.
